Pharmacy Image Repackaged cancer drug boosts delivery to tumors, improves combination therapies Aug. 21, 2025 BIO5 member Jianqin Lu and colleagues developed a new paclitaxel formulation, Paclitaxome, that improves drug delivery to tumors while reducing side effects. Read more in U of A Research and Partnerships Image Inside KEYS 2025 and the next generation of Arizona science July 24, 2025 Armed with curiosity and lab coats, the 2025 Class of the KEYS Research Internship didn’t just observe science; they shaped it. Read 12 of their stories. Read more in KEYS Image Drug discovery startup based on UA research receives $4 million seed funding May 20, 2025 Branch Therapeutics, a University of Arizona startup co-founded by BIO5 members Christopher Hulme and Curtis Thorne, has received $4 million in seed funding to advance its development of targeted therapies for cancer and other diseases. Read more in Tech Launch Arizona
Image Repackaged cancer drug boosts delivery to tumors, improves combination therapies Aug. 21, 2025 BIO5 member Jianqin Lu and colleagues developed a new paclitaxel formulation, Paclitaxome, that improves drug delivery to tumors while reducing side effects. Read more in U of A Research and Partnerships
Image Inside KEYS 2025 and the next generation of Arizona science July 24, 2025 Armed with curiosity and lab coats, the 2025 Class of the KEYS Research Internship didn’t just observe science; they shaped it. Read 12 of their stories. Read more in KEYS
Image Drug discovery startup based on UA research receives $4 million seed funding May 20, 2025 Branch Therapeutics, a University of Arizona startup co-founded by BIO5 members Christopher Hulme and Curtis Thorne, has received $4 million in seed funding to advance its development of targeted therapies for cancer and other diseases. Read more in Tech Launch Arizona
